Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.
Looking for a particular Korro Bio, Inc. employee's phone or email?
Korro Bio, Inc. Questions
The Korro Bio, Inc. annual revenue was $21.3 million in 2026.
Ram Aiyar is the CEO of Korro Bio, Inc..
95 people are employed at Korro Bio, Inc..
Korro Bio, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for Korro Bio, Inc. are [5417, 54, 541714, 54171, 541].
The SIC codes for Korro Bio, Inc. are [873, 87].
Top Korro Bio, Inc. Employees
-
Ram Aiyar
Chief Executive Officer at Korro Bio, Inc.
Boston, MA, US55+ -
Kemi Olugemo
Chief Medical Officer at Korro Bio, Inc.
United States35 -
Dana Mahadeo
Vice President, Intellectual Property at Korro Bio, Inc.
Cambridge, MA, US23 -
Gaozhong Zhu
SVP, CMC and Tech Ops at Korro Bio, Inc.
Cambridge, MA, US45+ -
Todd Chappell
Chief Operating Officer at Korro Bio, Inc.
Cambridge, MA, US24 -
2
-
21
-
Stephanie Engels
Chief People Officer at Korro Bio, Inc.
Lexington, MA, US35+
Related Companies
